Mechanism, made visible.
We make mechanism-of-action films for pharmaceutical teams. They clear medical review, and they take weeks.
This is your MOA slide. This is the same science, filmed.
Mechanism of Action
- GLP-1 receptor agonist with 94% sequence homology to native human GLP-1
- Stimulates insulin secretion in a glucose-dependent manner
- Suppresses inappropriate glucagon secretion
- Delays gastric emptying in the early postprandial phase
- Please see full Prescribing Information for approved uses
Figure adapted from data on file. Conceptual representation; not to scale. Individual results may vary. Refer to the full Prescribing Information.
Every claim has a source attached to it.
We log the claims before anyone writes a script. Medical review gets the list, with references, and can see which cut each one was signed off against.
| Claim | Source |
|---|---|
| Irreversible COX-1 acetylation | PI §12.1 |
| Reduced thromboxane A₂ synthesis | PI §12.2 |
| Effect lasts the life of the platelet, 7–10 days | Clinical overview |
| Recovery requires new platelet production | Clinical overview |
The whole production, in one window.
Brief to final master in one place. You can watch it happen, leave notes on the cut you’re actually looking at, and see what it costs while it runs.
00:1100:33
Version 3
00:18Tighten the NMDA blockade beat — it reads faster than the narration.
Approve masterRecent work.
Send us slide 14.
Pick the mechanism you explain most often, send the deck you explain it with, and we’ll come back with a plan and a price.
Start a projectOr write to hello@molecularframe.com